Klinique Medical Clinic Valuation
Is KLINIQ-R undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
1/6Valuation Score 1/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of KLINIQ-R when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: KLINIQ-R (THB31) is trading above our estimate of fair value (THB27.51)
Significantly Below Fair Value: KLINIQ-R is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for KLINIQ-R?
Key metric: As KLINIQ-R is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
| What is KLINIQ-R's PE Ratio? | |
|---|---|
| PE Ratio | 22.6x |
| Earnings | ฿301.38m |
| Market Cap | ฿6.82b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 2.4x |
| Enterprise Value/EBITDA | 12.8x |
| PEG Ratio | 1.3x |
Price to Earnings Ratio vs Peers
How does KLINIQ-R's PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 21.2x | ||
MEDEZE Medeze Group | 28x | 24.4% | ฿8.3b |
SAFE Safe Fertility Group | 18.3x | 11.8% | ฿3.6b |
GFC Genesis Fertility Center | 17.7x | 10.9% | ฿1.5b |
D Dental Corporation | 20.7x | n/a | ฿1.1b |
KLINIQ-R Klinique Medical Clinic | 22.6x | 17.8% | ฿6.8b |
Price-To-Earnings vs Peers: KLINIQ-R is expensive based on its Price-To-Earnings Ratio (22.6x) compared to the peer average (21.2x).
Price to Earnings Ratio vs Industry
How does KLINIQ-R's PE Ratio compare vs other companies in the TH Healthcare Industry?
| 0 Companies | Price / Earnings | Estimated Growth | Market Cap |
|---|
| 0 Companies | Estimated Growth | Market Cap |
|---|
Price-To-Earnings vs Industry: KLINIQ-R is expensive based on its Price-To-Earnings Ratio (22.6x) compared to the TH Healthcare industry average (22x).
Price to Earnings Ratio vs Fair Ratio
What is KLINIQ-R's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 22.6x |
| Fair PE Ratio | 24.8x |
Price-To-Earnings vs Fair Ratio: KLINIQ-R is good value based on its Price-To-Earnings Ratio (22.6x) compared to the estimated Fair Price-To-Earnings Ratio (24.8x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.